CTI Clinical Trial and Consulting Services (CTI) announced the acquisition of Eurotrials, a full-service contract research organization.
The acquisition strengthens CTI presence in Europe and Latin America. Eurotrials has offices in Argentina, Brazil, Chile, Mexico, Peru, Portugal and Spain, covering over 15 countries in both regions. Eurotrials provides an array of services from early- to late-stage research as well as product support in accordance with global and specific regional requirements. Additionally, the Eurotrials footprint augments CTI’s current reach, enabling CTI to better serve clients and global programs.
“We are excited to join our companies together to create a stronger full-service global clinical research organization,” according to Timothy J. Schroeder, CTI Founder and CEO. “This combined company will be one of the 20 largest CROs in the world, with associates in more than 30 countries across six continents. We believe this combined entity is the oldest, largest, privately owned CRO in the world with the founders still active in the company operations. We’re also thrilled that the leaders of Eurotrials, Maria João Queiroz and Inês Costa, will continue to play a large role in the organization.”
The terms of the acquisition were not disclosed. Plante Moran and Fifth Third Bank provided support to CTI throughout the acquisition.